The largest database of trusted experimental protocols

3 protocols using anti cd69 bv421 clone fn50

1

Evaluating KIR-Mediated Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Streptavidin Dynabeads were coated with biotinylated PVR (CD155), Nectin-2 (CD112), biotin, anti-KIR2DL1, anti-KIR2DL3, anti-KIR2DL5 and anti-KIR3DL1 as described before. 2.5 x 104 cells of each reporter cell line were seeded into a well of a tissue culture-treated 96-well plate and co-incubated with 10 μl of the protein-coated beads for 5 h at 37°C/5% CO2 in a final volume of 200 μl. For blocking experiments, prior to co-incubation with beads, KIR2DL5+ JRC were blocked for 30 min with 30 μg/ml purified anti-KIR2DL5 or 30 μg/ml purified IgG1 isotype control antibody. Blocking antibodies remained in the wells during the whole assay. After co-incubation, cells were washed with PBS and stained with the viability dye LIVE/DEAD Fixable Near-IR (Life Technologies), anti-CD3-BUV395 (clone UCHT1, BD Biosciences), anti-CD69-BV421 (clone FN50, Biolegend) and the appropriate KIR antibody conjugated to PE (anti-KIR2DL1-PE (clone REA284), anti-KIR2DL3-PE (clone REA147), anti-KIR2DL5-PE (clone UP-R1), anti-KIR3DL1-PE (clone DX9) (Miltenyi). Cells were fixed in CellFix (BD Biosciences) and CD69 expression as a readout for KIR crosslinking was analyzed by flow cytometry.
+ Open protocol
+ Expand
2

HLA-A2 Variant Peptide Presentation

Check if the same lab product or an alternative is used in the 5 most similar protocols
C1R cells expressing comparable levels of HLA-A2 D227K/T228A, wild-type HLA-A2, or HLA-A2 A245V/Kb were pulsed for 1 h with various concentrations of the indicated peptides. Cells were then washed twice with RPMI 1640 medium containing 100 U/mL penicillin and 100 μg/mL streptomycin and resuspended in R10. Each assay included 1.5 × 105 peptide-pulsed C1R cells and 5 × 104 MEL5 TCR+ CD8+ J.RT3-T3.5 cells. Unpulsed targets were used as negative controls. Expression of CD69 on the surface of MEL5 TCR+ CD8+ J.RT3-T3.5 cells was measured after 6 h using the following directly conjugated monoclonal antibodies: anti-CD8-α–PE-Cy7 (clone RPA-T8; Thermo Fisher Scientific), anti-CD8-β–eFluor660 (clone SIDI8BEE; Thermo Fisher Scientific), anti-CD69–BV421 (clone FN50; BioLegend), and anti-HLA-A2–FITC (clone BB7.2; BioLegend). Nonviable cells were excluded from the analysis using LIVE/DEAD Fixable Aqua (Thermo Fisher Scientific). Data were acquired using a NovoCyte Flow Cytometer (ACEA Biosciences) and analyzed using FlowJo software version 10.6.1 (FlowJo LLC).
+ Open protocol
+ Expand
3

Peptide Pulsing and CD69 Expression Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
C1R cells expressing HLA-A2 D227K/T228A, wildtype HLA-A2, or HLA-A2 A245V/K b were pulsed for 1 h with various concentrations of the peptides ELTGIGILTV (3T), ELAGIGILTV (ELA), or FATGIGIITV (FAT). Cells were then washed twice with RPMI 1640 medium containing 100 U/ml penicillin and 100 mg/ml streptomycin and resuspended in R10. Each assay included 1.5 × 10 5 peptide-pulsed C1R cells and 5 x 10 4 MEL5 TCR + CD8 + J.RT3-T3.5 cells. Unpulsed targets were used as negative controls. Expression of CD69 on the surface of MEL5 TCR + CD8 + J.RT3-T3.5 cells was measured after 6 h using the following directly conjugated monoclonal antibodies: anti-CD8α-PE-Cy7 (clone RPA-T8; Thermo Fisher Scientific), anti-CD8β-eFluor660 (clone SIDI8BEE; Thermo Fisher Scientific), anti-CD69-BV421 (clone FN50; BioLegend), and anti-HLA-A2-FITC (clone BB7.2; BioLegend).
Non-viable cells were excluded from the analysis using LIVE/DEAD Fixable Aqua (Thermo Fisher Scientific). Data were acquired using a NovoCyte Flow Cytometer (ACEA Biosciences) and analyzed using FlowJo software version 10.6.1 (FlowJo LLC).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!